extent of accumulation [NCA / SHAM]

posted by martin  – Austria, 2010-01-13 14:38 (5594 d 23:51 ago) – Posting: # 4595
Views: 21,056

Dear HS!

I have a question regarding estimating the extent of accumulation following repeated study drug administration. I have data from a single dose PK study and I would like to estimate the extent of accumulation in AUCs in the case of repeated study drug administrations.

According to Cawello (2003, page 61-62) "The extent of accumulation can be calculated by the ratio of the dosing interval to the half-life". Accumulation index R = 1/(1-2) where ε = dosing interval divided by half-life.

I suppose the accumulation is based on two assumptionsI have to questions in this context:
  1. In the case that the decline over time can be described by a biexponential decline (two-compartmental model) following an IV bolus with an initial and terminal phase which half-life should be used to estimate the extent of accumulation? I think the terminal half-life is not suitable as the theory of accumulation was developed on assumption of a one-compartmental model. right? I think the effective or non-compartmental half-life calculated as log(2) × MRT would be more suitable. Do you agree?
  2. In the case of only 2 to 4 repeated administration, steady state may not be reached according to Cawello (2003, page 58). In this case I would estimate the accumulation in AUCs based on the principle of superposition. Do you agree?

Best regards

Martin

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
164 visitors (0 registered, 164 guests [including 12 identified bots]).
Forum time: 15:30 CEST (Europe/Vienna)

Freedom is always and exclusively
freedom for the one
who thinks differently.    Rosa Luxemburg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5